Asbestos Research Today is a free monthly online journal that collates and summarizes the latest research about Asbestos, including details on mesothelioma, lung disease, dangers, effects, risks.

Volume 2 (2005), Issue 6 (June)

1. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
   J Thorac Cardiovasc Surg, 129(6): 1364-70. [Abstract] [Full-text]
2. Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases.
   Hum Pathol, 36(5): 465-73. [Abstract] [Full-text]
3. Asbestos and mesothelioma: worldwide trends.
   Lung Cancer, 49: S3-8. [Abstract] [Full-text]
4. Epidemic of mesothelioma in Egypt.
   Lung Cancer, 49: S17-20. [Abstract] [Full-text]
5. Transcriptional profiling of mesothelioma using microarrays.
   Lung Cancer, 49: S99-S103. [Abstract] [Full-text]
6. Implications of P16/CDKN2A deletion in pleural mesotheliomas.
   Lung Cancer, 49: S95-8. [Abstract] [Full-text]
7. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: the Heidelberg experience.
   Lung Cancer, 49: S83-6. [Abstract] [Full-text]
8. Treatment planning system evaluation for mesothelioma IMRT.
   Lung Cancer, 49: S75-81. [Abstract] [Full-text]
9. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience.
   Lung Cancer, 49: S71-4. [Abstract] [Full-text]
10. Molecular prognostic markers in malignant mesothelioma.
    Lung Cancer, 49: S53-60. [Abstract] [Full-text]
11. Malignant pleural mesothelioma: staging systems.
    Lung Cancer, 49: S45-8. [Abstract] [Full-text]
12. Computerized analysis of mesothelioma on CT scans.
    Lung Cancer, 49: S41-4. [Abstract] [Full-text]
13. CT, RECIST, and malignant pleural mesothelioma.
    Lung Cancer, 49: S37-40. [Abstract] [Full-text]
14. The role of PET in the surgical management of malignant pleural mesothelioma.
    Lung Cancer, 49: S27-32. [Abstract] [Full-text]
15. Overview on ongoing or planned clinical trials in Europe.
    Lung Cancer, 49: S117-21. [Abstract] [Full-text]
16. Clinical trials in malignant pleural mesothelioma in Australasia.
    Lung Cancer, 49: S113-6. [Abstract] [Full-text]
17. Soluble mesothelin-related protein--a blood test for mesothelioma.
    Lung Cancer, 49: S109-11. [Abstract] [Full-text]
18. Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma.
    Lung Cancer, 49: S65-8. [Abstract] [Full-text]
19. Prognostic factors in mesothelioma.
    Lung Cancer, 49: S49-52. [Abstract] [Full-text]
20. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma.
    Respirology, 10(3): 266-83. [Abstract] [Full-text]
21. SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure.
    Cancer Res, 65(12): 5256-62. [Abstract] [Full-text]
22. Validation of genomics-based prognostic tests in malignant pleural mesothelioma.
    Clin Cancer Res, 11(12): 4406-14. [Abstract] [Full-text]
23. Up-regulation of EphB4 in mesothelioma and its biological significance.
    Clin Cancer Res, 11(12): 4305-15. [Abstract] [Full-text]
24. Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature.
    Gynecol Oncol, 98(1): 161-7. [Abstract] [Full-text]

© 2004-2008 Asbestos Research Today. All Rights Reserved.